| Literature DB >> 21054823 |
Myron Maslanyj1, Tracy Lightfoot, Joachim Schüz, Zenon Sienkiewicz, Alastair McKinlay.
Abstract
BACKGROUND: Epidemiological evidence showing a consistent association between the risk of childhood leukaemia and exposure to power frequency magnetic fields has been accumulating. This debate considers the additional precautionary intervention needed to manage this risk, when it exceeds the protection afforded by the exposure guidelines as recommended by the International Commission on Non-Ionizing Radiation Protection.Entities:
Mesh:
Year: 2010 PMID: 21054823 PMCID: PMC3091578 DOI: 10.1186/1471-2458-10-673
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Summary evidence in terms of Bradford-Hill Criteria [14] for power frequency magnetic fields causing childhood leukaemia.
| Bradford-Hill Criterion | Power frequency magnetic fields | Ionising radiation |
|---|---|---|
| Pooled studies suggest a statistically significant doubling of risk above 0.3-0.4 uT. The strength of association is considered to be weak and only a small proportion of cases are attributable to high exposure. | Statistically significant raised risks of leukaemia are observed with increasing exposure to ionising radiation. Risk estimates are extrapolated from epidemiological data at higher doses using a linear no-threshold exposure response model. | |
| The association is observed almost exclusively in childhood case-control studies. | The association is observed in two different situations: first, studies of Japanese atomic bomb survivors irradiated as children, and second, studies of childhood cancer and antenatal exposure of the foetus to diagnostic X-rays. | |
| The association seems to be restricted to leukaemia, athough other childhood cancers have been investigated less frequently and less rigorously. | Studies have demonstrated that a number of different cancers are associated with exposure to ionising radiation. | |
| In ALL, the most common type of childhood leukaemia, the disease occurs relatively rapidly after exposure, normally in the third or fourth year of life. | In many of the cancers associated with ionising radiation, exposures can precede lesions by as much as several decades. | |
| There are too few data, even after pooling, to identify the shape of a possible dose-response relationship. Threshold exposure response models have been suggested although data are also compatible with other trends. | A linear-quadratic dose response relationship is found between childhood leukaemia and ionising radiation exposure in A-bomb survivor studies, except at the highest levels of exposure. The shape of the dose-response curve is uncertain at low doses. | |
| A number of mechanisms have been proposed for the interaction of magnetic fields with the human body, but it is unclear how these might affect the processes that lead to disease, particularly at the low levels identified in the epidemiological investigations. | There is a good mechanistic basis for suggesting ionising radiation causes leukaemia, involving direct damage to DNA. There are also other processes that have the potential to modify the simple model. There is abundant | |
| The cause of childhood leukaemia is complex and not well enough understood to make an assessment. | The observed associations are consistent with what is known about the carcinogenic effects of ionisation radiation. | |
| Evidence that removing the exposure reduces disease would be difficult to ascertain because of the small fraction affected. | Evidence is difficult to ascertain. | |
| No analogies in adjacent parts of the electromagnetic spectrum. | A leukaemogenic effect is consistent with what is known about ionising radiation causing a range of cancers. | |
For comparison purposes, the same criteria are considered for ionising radiation causing leukaemia
Figure 1Pooled relative risk estimates from the Ahlbom [4].
Power frequency magnetic fields and the risk of childhood leukaemia - results from nine studies included in the pooled analysis of Ahlbom et al [4]
| Leukaemia cases | |||
|---|---|---|---|
| Odds Ratio (95% CI) | Observed | Expected | |
| Canada | 1.55 (0.65 - 3.68) | 13 | 10 |
| USA | 3.44 (1.24 - 9.54) | 17 | 5 |
| UK | 1.00 (0.30 - 3.37) | 4 | 4 |
| Norway | 0 cases, 10 controls | 0 | 3 |
| Germany | 2.00 (0.26-15.17) | 5 | 2 |
| Sweden | 3.74 (1.23 - 11.4) | 5 | 2 |
| Finland | 6.21 (0.68 - 56.9) | 1 | 0 |
| Denmark | 2 cases, 0 controls | 2 | 0 |
| New Zealand | 0 cases, 0 controls | 0 | 0 |
| Total | 2.00 (1.27 - 3.13) | 47 | 26 |
Figure 2The costs of wrong decisions for high and low level interventions to reduce exposure.